ProfessionalDiscontinued

Charles S. Grob, M.D, endorses Healthcare Practitioner Access to Psilocybin for Professional Training

This page presents TheraPsil’s case for allowing healthcare professionals approved to conduct psychedelic treatment to have first-hand psilocybin experience as part of professional training. It includes a letter of support from Charles S. Grob, M.D. and background on TheraPsil’s training efforts.

Provider

English

Details

30 years

Enrollment

Price on request
This course is currently marked as discontinued.

Course Overview

TheraPsil describes a need for more qualified healthcare professionals trained in psilocybin-assisted psychotherapy. The page explains that TheraPsil has been developing a training program that combines lectures, case studies, readings, discussions, and experiential learning. The featured material is a letter of support from Charles S. Grob, M.D., who argues that therapists who will guide psychedelic treatment may benefit from personal experience with psychedelics in order to better support patients and maintain safety. The content is intended for healthcare professionals, therapists, clinical counselors, nurses, social workers, and others involved in psilocybin-assisted psychotherapy or professional training related to psychedelic treatment.

Who is this for?

Healthcare professionals involved in psilocybin-assisted psychotherapy, including doctors, therapists, clinical counselors, nurses, social workers, and related practitioners.

Prerequisites

None stated on the page.

About the Provider

TheraPsil is a Canadian nonprofit focused on legal access to psychedelic-assisted therapy for people in medical need. Its current public work spans patient navigation, prescriber and therapist training, referrals, and sustained advocacy around federal access pathways. The organization remains one of the clearest Canadian patient-access stakeholders because it links policy work to concrete care pathways. Current materials show active work on Project Solace, ongoing clinician upskilling, and new Manitoba progress around MDMA-assisted therapy.

View TheraPsil profile

Course Details

  • PricePrice on request
  • Lifecycle statusDiscontinued
  • Skills
    IntegrationFacilitationPsychotherapyPsilocybin TherapyMDMA-Assisted Therapypsilocybin-assisted psychotherapy contextpatient safety awarenesstherapeutic support in altered states of consciousnesspost-experience integrationprofessional training in psychedelic carepsilocybin-assisted psychotherapypsychedelic therapy trainingclinical support for psychedelic treatmenttherapeutic safety and patient support
  • Categories